Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome.

J M Henderson1, W D Warren, W J Millikan

  • 1Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.

American Journal of Surgery
|January 1, 1990
PubMed
Summary

Budd-Chiari syndrome management depends on disease stage. Acute cases with hepatocyte necrosis benefit from decompressive shunts, while chronic, irreversible damage necessitates liver transplantation for optimal outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation of Energy Used by Foodservice Infrared Heating Equipment with Bentonite Models of Menu Items <sup>1</sup>.

Journal of food protection·2019
Same author

Three Cases of Combined Leprosy and Dermal Leishmaniasis.

The Indian medical gazette·2017
Same author

Abdominal Pain in a Football Player.

The Physician and sportsmedicine·2016
Same author

Patient and disease factors predictive of adverse perioperative outcomes after nephrectomy.

Annals of the Royal College of Surgeons of England·2016
Same author

Wound dressing following debridement for Fournier's gangrene.

Annals of the Royal College of Surgeons of England·2014
Same author

Operational planning for the malaria control in war areas DDT residual house spraying program.

Proceedings, annual meeting - New Jersey Mosquito Extermination Association·2010

Area of Science:

  • Hepatology
  • Vascular Surgery
  • Transplant Surgery

Background:

  • Budd-Chiari syndrome is a rare condition characterized by hepatic venous outflow obstruction.
  • Effective management strategies are crucial for improving patient prognosis.

Purpose of the Study:

  • To present a management scheme for Budd-Chiari syndrome based on clinical experience.
  • To correlate disease severity with therapeutic interventions and outcomes.

Main Methods:

  • Retrospective analysis of 33 Budd-Chiari syndrome patients.
  • Therapeutic decisions guided by liver biopsy findings (hepatocyte necrosis, fibrosis) and intrahepatic vena cava obstruction.
  • Evaluation of shunt types (mesoatrial vs. portacaval) and their associated morbidity.
  • Assessment of liver function using galactose elimination capacity.

Related Experiment Videos

  • Hematologic evaluation for myeloproliferative disorders.

    • Main Results:

    • Liver biopsy findings dictated acute Budd-Chiari syndrome management; hepatocyte necrosis indicated shunt placement.
    • Mesoatrial shunts had higher morbidity than portacaval shunts.
    • Successful shunts stabilized liver function (galactose elimination capacity maintained).
    • Severe fibrosis and reduced galactose elimination capacity signaled advanced disease, requiring liver transplant.
    • Myeloproliferative disorders were identified in 8/13 patients, managed with anticoagulation/chemotherapy to prevent recurrent thrombosis.

    Conclusions:

    • Budd-Chiari syndrome management is stage-dependent.
    • No biopsy injury may require no therapy.
    • Acute, reversible injury is managed with decompressive shunts.
    • Irreversible damage necessitates liver transplantation.
    • Comprehensive patient evaluation is key for selecting appropriate therapy.